Bioventix Announcements
On this page you will find recent press releases that are accessible by clicking on the links below. The latest press releases can also be found on our AIM announcements page. Shareholder meetings and any investor related announcements will also be posted here and to the above link.
TR-1: Notification of major interest in shares. To download this report as a PDF file click here.
Bioventix plc (“Bioventix” or the “Company”) Director/PDMR Shareholdings and Issue of Equity Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of [...]
TR-1: Notification of major interest in shares. To download this report as a PDF file click here.
TR-1: Notification of major interest in shares. To download this report as a PDF file click here.
Bioventix plc (“Bioventix” or the “Company”) Result of AGM Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting held earlier today, all resolutions put to shareholders were [...]
Bioventix plc (“Bioventix” or “the Company”) Director Dealing Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal [...]
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, confirms that its Annual [...]
Bioventix plc (“Bioventix” or “the Company”) Director Dealing Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for [...]
Bioventix plc (BVXP) announces its audited results for the year ended 30 June 2022 Highlights: Revenue up 7% to £11.72 million (2021: £10.93 million) Profit before tax up 14% to £9.28 million [...]
Bioventix plc is an AIM listed company. This site contains key corporate, financial and shareholder information. The information disclosed is for the purposes of AIM Rule 26. Bioventix plc is subject to the UK City Code on Takeovers and Mergers.
